madman
Super Moderator
The Food and Drug Administration's (FDA) Office of Women's Health and the Center for Drug Evaluation and Research are announcing a public workshop titled "Testosterone Use in Menopausal Women."
The purpose of the public workshop is to examine the current scientific evidence and critical knowledge gaps related to testosterone use in menopausal women to help inform future research and potential drug development of testosterone products for menopausal women.
The public workshop will be held on September 17, 2026, from 9:00 a.m. to 4:30 p.m. Eastern Time as a hybrid event via webcast and an in-person option at the FDA White Oak Campus, Great Room, Bldg. 31, 10903 New Hampshire Ave., Silver Spring, MD 20993.
Entrance for public workshop participants (non-FDA employees) is through Building 1, where routine security check procedures will be performed. ⚠ Important Registration NoticeIN-PERSON REGISTRATION CLOSES ON SEPTEMBER 10 OR ONCE MAXIMUM CAPACITY IS REACHED. Virtual registration will remain open after this date. If you plan to attend in person, please complete your registration as early as possible to secure your spot. All in-person attendees are required to bring a printed or digital copy of their registration confirmation to the meeting for check-in.Media InquiriesPlease direct all media inquiries to the HHS Office of the Assistant Secretary for Public Affairs (ASPA):
https://hhscewp.my.site.com/ASPAPublic/s/request-for-commentFor additional meeting information see:Testosterone Use in Menopausal Women
REGISTER HERE:
Attachments
Last edited by a moderator: